Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial

Kazumoto Iijima, Mayumi Sako(National Center For Child Health and Development), Kandai Nozu(Kobe University), Rintaro Mori(National Center For Child Health and Development), Nao Tuchida(National Center For Child Health and Development), Koichi Kamei(National Center For Child Health and Development), Kenichiro Miura(The University of Tokyo), Kunihiko Aya(Okayama University), Koichi Nakanishi(Wakayama Medical University), Yoshiyuki Ohtomo(Juntendo University Nerima Hospital), Shori Takahashi(Surugadai Nihon University Hospital), Ryojiro Tanaka(Kobe Children's Hospital), Hiroshi Kaito(Kobe University), Hidefumi Nakamura(National Center For Child Health and Development), Kenji Ishikura(Tokyo Metropolitan Children's Medical Center), Shuichi Ito(National Center For Child Health and Development), Yasuo Ohashi(Chuo University)
The Lancet
June 22, 2014
Cited by 441

Abstract


Related Papers

No related papers found

Powered by citation graph analysis